Cancer history: Growth factor-modulating peptides like Dihexa may warrant avoidance in those with cancer history, though evidence for concern remains theoretical
Supplementary data The following are the Supplementary data to this article: References 1.Bai L., Lennon D.P., Caplan A.I., DeChant A., Hecker J., Kranso J.Miller R.H
Prodromal PD: a new nosological entity
Clinical services, including medical consultations and prescribing decisions, are provided by independent, licensed healthcare providers who exercise their own professional judgment
Best grey market peptide vendors 2026 ranked research peptide suppliers, Finnrick-tested retatrutide sources, Reddit checks, and Peptide Sciences alternatives